Literature DB >> 15053338

CD8+ T-cells: function and response to HIV infection.

Naveed Gulzar1, Karen F T Copeland.   

Abstract

CD8+ T-cells are a critical component of the cellular immune response and they play an important role in the control of viral infection. During HIV infection, CD8+ T-cells are able to recognize infected cells through an MHC-I dependent process and are able to lyse cells harboring viral infection by the secretion of perforin and granzymes. These cytotoxic T-lymphocytes (CTL) can also eliminate virally infected cells through the engagement of death-inducing ligands expressed by CD8+ T-cells with death receptors on the surface of the infected cell. In addition, CD8+ CTL secrete soluble factors such as beta-chemokines and the CD8+ antiviral factor (CAF) that suppress viral binding and transcription, respectively. In order for HIV to survive the pressures placed upon it by the immune system, the virus has adopted numerous strategies to evade the CD8+ T-cell response. The high mutation rate of HIV has allowed the virus to escape CD8+ T-cell recognition in addition to its ability to down-regulate surface MHC-I expression from infected cells. Also, by altering the pattern of cytokine production and engagement of cellular receptors, HIV disrupts proper CD8+ T-cell signaling. The resultant improper T-cell receptor (TcR) stimulation creates an anergic state in these cells. By affecting the function of CD4+ T-cells and antigen presenting cells that are required for proper CD8+ T-cell maturation, HIV is able to decrease the circulating pool of effector and memory CD8+ T-cells that are able to combat viral infection. The end result is the aberration of CD8+ T-cell function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053338     DOI: 10.2174/1570162043485077

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  49 in total

1.  Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects.

Authors:  Hanâ Baba; Anass Kettani; Meryem Bouqdayr; Ahd Ouladlahsen; Rajaa Bensghir; Latifa Marih; Mustapha Sodqi; Soumaya Benjelloun; Sayeh Ezzikouri; Imane Zaidane; Fatima-Zahra Jadid; Kamal Marhoum El Filali; Lahcen Wakrim
Journal:  Med Microbiol Immunol       Date:  2021-05-24       Impact factor: 3.402

2.  In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.

Authors:  Benigno Rodriguez; Hernan Valdez; Christoph G Lange; Robert Asaad; Kathy Medvik; Scott F Sieg
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

3.  Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.

Authors:  Masakazu Kamata; Patrick Y Kim; Hwee L Ng; Gene-Errol E Ringpis; Emiko Kranz; Joshua Chan; Sean O'Connor; Otto O Yang; Irvin S Y Chen
Journal:  Biochem Biophys Res Commun       Date:  2015-05-19       Impact factor: 3.575

4.  Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Authors:  Jennifer L Kelschenbach; Manisha Saini; Eran Hadas; Chao-Jiang Gu; Wei Chao; Galina Bentsman; Jessie P Hong; Tomas Hanke; Leroy R Sharer; Mary Jane Potash; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-11       Impact factor: 4.147

5.  A proposal to use iterative, small clinical trials to optimize therapeutic HIV vaccine immunogens to launch therapeutic HIV vaccine development.

Authors:  Stuart Z Shapiro
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

6.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

7.  HIV-induced changes in T cell signaling pathways.

Authors:  Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  Dynamic correlation between CTL response and viral load in primary human immunodeficiency virus-1 infected Koreans.

Authors:  Gab Jung Kim; Hak Sung Lee; Kee-Jong Hong; Sung Soon Kim
Journal:  Virol J       Date:  2010-09-16       Impact factor: 4.099

9.  CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Hossein Keshavarz; Rosita Edalat; Abdolfattah Sarrafnejad; Tahereh Shahrestani; Fereidoun Mahboudi; Ali Khamesipour
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

10.  The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.

Authors:  Irina Tcherepanova; Aijing Starr; Brad Lackford; Melissa D Adams; Jean-Pierre Routy; Mohamed Rachid Boulassel; David Calderhead; Don Healey; Charles Nicolette
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.